Pharvaris (PHVS) FCF Payout Ratio (2020 - 2026)
Pharvaris' (PHVS) quarterly FCF Payout Ratio came in at 5.07 in Q1 2026, up 17.88% YoY from 4.3 in Q1 2025, and up 100.0% on a QoQ basis from 7685617.45 in Q4 2025.
Pharvaris (PHVS) FCF Payout Ratio (2020 - 2026) Analysis & Trends
Pharvaris (PHVS) has 7 years of FCF Payout Ratio data on file, last reported at 5.07 in Q1 2026.
- Quarterly FCF Payout Ratio rose 17.88% year-over-year to 5.07 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1985589.07 (up 5.06% YoY) and the FY2025 annual result came in at 2130457.87, up 9.24% from the prior year.
- FCF Payout Ratio climbed to 5.07 in Q1 2026, from 7685617.45 in the prior quarter.
- In the past five years, FCF Payout Ratio ranged from a high of 1.23 in Q2 2025 to a low of 16451765.06 in Q4 2023.
- A 5-year average of 2361373.42 and a median of 5.07 in 2026 frame the typical range for FCF Payout Ratio.
- Annual changes were most pronounced in 2023 — FCF Payout Ratio plunged 1726.1% — and 2024, when it surged 129.66%.
- Tracing PHVS's FCF Payout Ratio over 5 years: stood at 7937347.6 in 2022, then sank by 107.27% to 16451765.06 in 2023, then soared by 50.96% to 8068566.32 in 2024, then increased by 4.75% to 7685617.45 in 2025, then surged by 100.0% to 5.07 in 2026.
- The last three FCF Payout Ratio figures came in at 5.07 (Q1 2026), 7685617.45 (Q4 2025), and 4.23 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.17 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.07 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Pharvaris | 2.29 Bn | 1.92 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.07 |
| Dec 31, 2025 | -7.69 Mn |
| Sep 30, 2025 | -4.23 |
| Jun 30, 2025 | 1.23 |
| Mar 31, 2025 | -6.17 |
| Dec 31, 2024 | -8.07 Mn |
| Sep 30, 2024 | 1.16 |
| Jun 30, 2024 | 0.90 |
| Mar 31, 2024 | -15.22 |
| Dec 31, 2023 | -16.45 Mn |
| Sep 30, 2023 | -3.93 |
| Jun 30, 2023 | -3.93 |
| Mar 31, 2023 | -5.37 |
| Dec 31, 2022 | -7.94 Mn |
| Sep 30, 2022 | 0.24 |
| Jun 30, 2022 | -0.48 |
| Mar 31, 2022 | -10.91 |
| Dec 31, 2021 | -16.84 Mn |
| Sep 30, 2021 | 0.57 |
| Jun 30, 2021 | 1.18 |